Bulgaria's Sopharma sales fall 11% y/y in Q1

Revenue from export sales fell by 16% year-on-year in January-March, whereas sales on the domestic market tumbled 1%, Sopharma said in a bourse filing.

In March alone, Sopharma recorded a 24% annual drop in sales revenue. The company's export sales sank by 32% on the year, while domestic sales lost 8%.

As of 1500 CET on Monday, shares in Sopharma traded 0.66% lower at 6.00 levs ($3.27/3.07 euro) on the Bulgarian Stock Exchange.

(1 euro = 1.95583 levs)